Daniel P. Fitzgerald

920 total citations
16 papers, 731 citations indexed

About

Daniel P. Fitzgerald is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel P. Fitzgerald has authored 16 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel P. Fitzgerald's work include Brain Metastases and Treatment (4 papers), Axon Guidance and Neuronal Signaling (4 papers) and Glioma Diagnosis and Treatment (3 papers). Daniel P. Fitzgerald is often cited by papers focused on Brain Metastases and Treatment (4 papers), Axon Guidance and Neuronal Signaling (4 papers) and Glioma Diagnosis and Treatment (3 papers). Daniel P. Fitzgerald collaborates with scholars based in United States, Australia and Germany. Daniel P. Fitzgerald's co-authors include Welcome Bender, Patricia S. Steeg, Diane Palmieri, Yongzhen Qian, Emily Hua, Robert J. Weil, Andreas M. Stark, Helen Cooper, Seth M. Steinberg and Jeanne M. Herring and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and Development.

In The Last Decade

Daniel P. Fitzgerald

14 papers receiving 720 citations

Peers

Countries citing papers authored by Daniel P. Fitzgerald

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Fitzgerald more than expected).

Fields of papers citing papers by Daniel P. Fitzgerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Fitzgerald. The network helps show where Daniel P. Fitzgerald may publish in the future.

Co-authorship network of co-authors of Daniel P. Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Fitzgerald. A scholar is included among the top collaborators of Daniel P. Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Fitzgerald. Daniel P. Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The FLRT3-UNC5B checkpoint pathway inhibits T cell–based cancer immunotherapies 2024 ·Science Advances ·(unknown), Chuan Yan, Qiqi Yang, (unknown), Daniel P. Fitzgerald, (unknown), Jahangheer Shaik, (unknown), K. Myers, (unknown), (unknown), (unknown), (unknown), Zachary Cusumano, Solomon Langermann, David M. Langenau, Shashank J. Patel, Dallas B. Flies	1
2	Abstract 1898: LNCB74 is a potent and safe next-generation antibody-drug-conjugate utilizing a cancer selective linker for the treatment of B7-H4 expressing cancers 2024 ·Cancer Research ·Daniel P. Fitzgerald, (unknown), (unknown), Shannon M. Kahan, (unknown), (unknown), Kwang Hwa Jung, Hwanhee Oh, (unknown), (unknown), Shanmugam Panneer Selvam, Dallas B. Flies, Chul‐Woong Chung, Sol Langermann	0
3	1051 LNCB74 is a B7-H4 targeting antibody-drug-conjugate with a β-glucuronide linker-MMAE payload system to enhance the therapeutic index in B7-H4 expressing cancers 2024 ·Regular and Young Investigator Award Abstracts ·Shannon M. Kahan, Daniel P. Fitzgerald, (unknown), Ngoc‐Duc Doan, (unknown), (unknown), (unknown), (unknown), Hwanhee Oh, (unknown), (unknown), Shanmugam Panneer Selvam, Dallas B. Flies, (unknown), Chul‐Woong Chung, Sol Langermann	0
4	TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells 2012 ·Molecular Cancer Therapeutics ·Daniel P. Fitzgerald, David L. Emerson, Yongzhen Qian, Talha Anwar, David J. Liewehr, Seth M. Steinberg, Sandra Silberman, Diane Palmieri, Patricia S. Steeg	69
5	Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage 2012 ·Cancer Research ·Daniel P. Fitzgerald, Preeti Subramanian, Monika Deshpande, (unknown), Ira K. Gordon, Yongzhen Qian, (unknown), David J. Liewehr, Seth M. Steinberg, (unknown), Mary M. Herman, Kevin Camphausen, Diane Palmieri, S. Patricia Becerra, Patricia S. Steeg	48
6	Identification of Pigment Epithelium-Derived Factor Protein Forms with Distinct Activities on Tumor Cell Lines 2012 ·SHILAP Revista de lepidopterología ·Preeti Subramanian, Monika Deshpande, Silvia Locatelli‐Hoops, (unknown), Denisse A. Gutiérrez, Daniel P. Fitzgerald, (unknown), (unknown), Vicente Notario, S. Patricia Becerra	18
7	A Conceptual Design Tool for Resolving Conflicts Between Product Functionality and Environmental Impact 2010 ·Journal of Mechanical Design ·Daniel P. Fitzgerald, Jeffrey W. Herrmann, Linda C. Schmidt	27
8	Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis 2009 ·Molecular Cancer Research ·Diane Palmieri, Daniel P. Fitzgerald, S. Martin Shreeve, Emily Hua, Julie L. Bronder, Robert J. Weil, Sean Davis, Andreas M. Stark, Maria J. Merino, Raffael Kurek, H. Maximilian Mehdorn, Gary L. Davis, Seth M. Steinberg, Paul S. Meltzer, Kenneth Aldape, Patricia S. Steeg	173
9	Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization 2008 ·Clinical & Experimental Metastasis ·Daniel P. Fitzgerald, Diane Palmieri, Emily Hua, (unknown), Jeanne M. Herring, Yongzhen Qian, Eleazar Vega-Valle, Robert J. Weil, Andreas M. Stark, Alexander O. Vortmeyer, Patricia S. Steeg	168
10	Neogenin is expressed on neurogenic and gliogenic progenitors in the embryonic and adult central nervous system 2007 ·Gene Expression Patterns ·Daniel P. Fitzgerald, DanaKai Bradford, Helen Cooper	24
11	Localization of Neogenin protein during morphogenesis in the mouse embryo 2006 ·Developmental Dynamics ·Daniel P. Fitzgerald, (unknown), Helen Cooper	28
12	Characterization of neogenin-expressing neural progenitor populations and migrating neuroblasts in the embryonic mouse forebrain 2006 ·Neuroscience ·Daniel P. Fitzgerald, (unknown), (unknown), (unknown), Helen Cooper	33
13	Beyond Tools: A Design for Environment Process 2005 ·International Journal of Performability Engineering ·Daniel P. Fitzgerald, Jeffrey W. Herrmann, Peter Sandborn, Linda C. Schmidt, (unknown)	11
14	Using the Decision Production Systems Approach to Improve Product Development 2005 ·Daniel P. Fitzgerald, Jeffrey W. Herrmann, Peter Sandborn, Linda C. Schmidt	1
15	Transcription activates repressed domains in theDrosophilabithorax complex 2002 ·Development ·Welcome Bender, Daniel P. Fitzgerald	72
16	Polycomb Group Repression Reduces DNA Accessibility 2001 ·Molecular and Cellular Biology ·Daniel P. Fitzgerald, Welcome Bender	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact